These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 28283659)

  • 21. Regulation of MHC class II expression and antigen processing in murine and human mesenchymal stromal cells by IFN-gamma, TGF-beta, and cell density.
    Romieu-Mourez R; François M; Boivin MN; Stagg J; Galipeau J
    J Immunol; 2007 Aug; 179(3):1549-58. PubMed ID: 17641021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon-Gamma Primed Human Clonal Mesenchymal Stromal Cell Sheets Exhibit Enhanced Immunosuppressive Function.
    Dunn CM; Kameishi S; Cho YK; Song SU; Grainger DW; Okano T
    Cells; 2022 Nov; 11(23):. PubMed ID: 36497001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunosuppressive capabilities of mesenchymal stromal cells are maintained under hypoxic growth conditions and after gamma irradiation.
    Nold P; Hackstein H; Riedlinger T; Kasper C; Neumann A; Mernberger M; Fölsch C; Schmitt J; Fuchs-Winkelmann S; Barckhausen C; Killer M; Neubauer A; Brendel C
    Cytotherapy; 2015 Feb; 17(2):152-62. PubMed ID: 25453724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional Profiling of Chondrogenically Induced Multipotent Stromal Cell Aggregates Reveals Transcriptomic and Emergent Morphological Phenotypes Predictive of Differentiation Capacity.
    Lam J; Bellayr IH; Marklein RA; Bauer SR; Puri RK; Sung KE
    Stem Cells Transl Med; 2018 Sep; 7(9):664-675. PubMed ID: 30084545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discrepancy between the in vitro and in vivo effects of murine mesenchymal stem cells on T-cell proliferation and collagen-induced arthritis.
    Schurgers E; Kelchtermans H; Mitera T; Geboes L; Matthys P
    Arthritis Res Ther; 2010; 12(1):R31. PubMed ID: 20175883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stem cells isolated from the human stromal limbus possess immunosuppressant properties.
    Garfias Y; Nieves-Hernandez J; Garcia-Mejia M; Estrada-Reyes C; Jimenez-Martinez MC
    Mol Vis; 2012; 18():2087-95. PubMed ID: 22876135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mesenchymal stromal cells expressing ErbB-2/neu elicit protective antibreast tumor immunity in vivo, which is paradoxically suppressed by IFN-gamma and tumor necrosis factor-alpha priming.
    Romieu-Mourez R; François M; Abate A; Boivin MN; Birman E; Bailey D; Bramson JL; Forner K; Young YK; Medin JA; Galipeau J
    Cancer Res; 2010 Oct; 70(20):7742-7. PubMed ID: 20924101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel direct co-culture assay analyzed by multicolor flow cytometry reveals context- and cell type-specific immunomodulatory effects of equine mesenchymal stromal cells.
    Hillmann A; Paebst F; Brehm W; Piehler D; Schubert S; Tárnok A; Burk J
    PLoS One; 2019; 14(6):e0218949. PubMed ID: 31247035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing.
    François M; Copland IB; Yuan S; Romieu-Mourez R; Waller EK; Galipeau J
    Cytotherapy; 2012 Feb; 14(2):147-52. PubMed ID: 22029655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IFN-γ and TNF-α Pre-licensing Protects Mesenchymal Stromal Cells from the Pro-inflammatory Effects of Palmitate.
    Boland L; Burand AJ; Brown AJ; Boyt D; Lira VA; Ankrum JA
    Mol Ther; 2018 Mar; 26(3):860-873. PubMed ID: 29352647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3-dioxygenase-1 via interferon-beta and protein kinase R.
    Opitz CA; Litzenburger UM; Lutz C; Lanz TV; Tritschler I; Köppel A; Tolosa E; Hoberg M; Anderl J; Aicher WK; Weller M; Wick W; Platten M
    Stem Cells; 2009 Apr; 27(4):909-19. PubMed ID: 19353519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multipotent mesenchymal stromal cells express FoxP3: a marker for the immunosuppressive capacity?
    Sundin M; D'arcy P; Johansson CC; Barrett AJ; Lönnies H; Sundberg B; Nava S; Kiessling R; Mougiakakos D; Le Blanc K
    J Immunother; 2011 May; 34(4):336-42. PubMed ID: 21499129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity of human mesenchymal stem cells in HLA-class I-restricted T-cell responses against viral or tumor-associated antigens.
    Morandi F; Raffaghello L; Bianchi G; Meloni F; Salis A; Millo E; Ferrone S; Barnaba V; Pistoia V
    Stem Cells; 2008 May; 26(5):1275-87. PubMed ID: 18292209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Equine mesenchymal stromal cells from different tissue sources display comparable immune-related gene expression profiles in response to interferon gamma (IFN)-γ.
    Cassano JM; Fortier LA; Hicks RB; Harman RM; Van de Walle GR
    Vet Immunol Immunopathol; 2018 Aug; 202():25-30. PubMed ID: 30078595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison of Biological Characteristics and Immunosuppressive Activity between Human Amniotic Mesenchymal Stem Cells and Human Bone Marrow Mesenchymal Stem Cells].
    Hong JQ; Gao Y; Song J; Zhuo WB; Sun HT; Ping BH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):858-64. PubMed ID: 27342523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA-G and CD152 Expression Levels Encourage the Use of Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells as an Alternative for Immunosuppressive Therapy.
    Zoehler B; Fracaro L; Boldrini-Leite LM; da Silva JS; Travers PJ; Brofman PRS; Bicalho MDG; Senegaglia AC
    Cells; 2022 Apr; 11(8):. PubMed ID: 35456019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A reproducible immunopotency assay to measure mesenchymal stromal cell-mediated T-cell suppression.
    Bloom DD; Centanni JM; Bhatia N; Emler CA; Drier D; Leverson GE; McKenna DH; Gee AP; Lindblad R; Hei DJ; Hematti P
    Cytotherapy; 2015 Feb; 17(2):140-51. PubMed ID: 25455739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-22 drives the proliferation, migration and osteogenic differentiation of mesenchymal stem cells: a novel cytokine that could contribute to new bone formation in spondyloarthropathies.
    El-Zayadi AA; Jones EA; Churchman SM; Baboolal TG; Cuthbert RJ; El-Jawhari JJ; Badawy AM; Alase AA; El-Sherbiny YM; McGonagle D
    Rheumatology (Oxford); 2017 Mar; 56(3):488-493. PubMed ID: 27940584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunomodulatory effects of fetal and adult mesenchymal stem cells.
    Le Blanc K
    Cytotherapy; 2003; 5(6):485-9. PubMed ID: 14660044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety Profile of Good Manufacturing Practice Manufactured Interferon γ-Primed Mesenchymal Stem/Stromal Cells for Clinical Trials.
    Guess AJ; Daneault B; Wang R; Bradbury H; La Perle KMD; Fitch J; Hedrick SL; Hamelberg E; Astbury C; White P; Overolt K; Rangarajan H; Abu-Arja R; Devine SM; Otsuru S; Dominici M; O'Donnell L; Horwitz EM
    Stem Cells Transl Med; 2017 Oct; 6(10):1868-1879. PubMed ID: 28887912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.